Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04828252
Other study ID # A-ER-109-187
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 9, 2020
Est. completion date June 4, 2021

Study information

Verified date February 2021
Source National Cheng-Kung University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was to investigate the intervention effects of low level laser for knee OA group


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date June 4, 2021
Est. primary completion date June 4, 2021
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - The severity of osteoarthritis was defined by the Kellgren-Lawrence system as grade 2 - grade 3 Exclusion Criteria: - Uncontrolled hypertension - Malignant tumor - Skin cancer - Pregnant - Dysesthesia - Pacemaker inplement - Cognitive problem - Fall record within 6 months - Dysfunction of blood coagulation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Low level laser treatment
The intervention protocol includes 2 wavelength as the experimental group, each of the were 808nm, 660nm, and 1 placebo intervention which output total power is only 0.0072W.

Locations

Country Name City State
Taiwan Department of Physical Therapy, National Cheng-Kung University Tainan

Sponsors (1)

Lead Sponsor Collaborator
National Cheng-Kung University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes of joint range of motion measured by the goniometer Joint range of motion of the hip flexion, internal and external rotation, knee flexion, extension on both sides(degrees) Baseline and after treatment, 8 weeks intervention
Primary Changes of muscular strength of thigh measured by handheld dynamometer Muscular strength of the knee extensor and flexor on both sides and will be normalized by the body weight of participants' (lb/kg) Baseline and after treatment, 8 weeks intervention
Secondary Changes of walking speed measured by the stop watch 40-m walk test, participants are instructed to walk as fast as they could, investigator records the time they spend. (seconds) Baseline and after treatment, 8 weeks intervention
Secondary Changes of stair climbing ability measured by the stop watch stair climbing test, participants are instructed to climb stairs with a total height of 180 cm as fast as they could, investigator records the time they spend. (seconds) Baseline and after treatment, 8 weeks intervention
Secondary Changes of chair stand ability, the stop watch will be used to measure time and investigators count the time that participants complete sit-to-stand test, participants are instructed to repeat chair stand movement as fast as they could, investigator records the times they complete. (times) Baseline and after treatment, 8 weeks intervention
Secondary Changes of dynamic balance ability measured by the stop watch timed UP&Go test, participants are instructed to stand up from a chair and walk as fast as they could for 3 meters and back to the chair, investigator records the time they spend. (seconds) Baseline and after treatment, 8 weeks intervention
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Completed NCT02881775 - Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis N/A
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2